Windlas Biotech Balance Sheet Health
Financial Health criteria checks 6/6
Windlas Biotech has a total shareholder equity of ₹4.2B and total debt of ₹63.1M, which brings its debt-to-equity ratio to 1.5%. Its total assets and total liabilities are ₹5.7B and ₹1.5B respectively. Windlas Biotech's EBIT is ₹591.4M making its interest coverage ratio -23.7. It has cash and short-term investments of ₹1.7B.
Key information
1.5%
Debt to equity ratio
₹63.06m
Debt
| Interest coverage ratio | -23.7x |
| Cash | ₹1.69b |
| Equity | ₹4.16b |
| Total liabilities | ₹1.54b |
| Total assets | ₹5.70b |
Recent financial health updates
No updates
Recent updates
Is Now The Time To Put Windlas Biotech (NSE:WINDLAS) On Your Watchlist?
Nov 03
Windlas Biotech (NSE:WINDLAS) Is Increasing Its Dividend To ₹4.00
Aug 20Windlas Biotech (NSE:WINDLAS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
May 23Windlas Biotech Limited's (NSE:WINDLAS) Shares Lagging The Market But So Is The Business
Apr 07Financial Position Analysis
Short Term Liabilities: WINDLAS's short term assets (₹3.9B) exceed its short term liabilities (₹1.5B).
Long Term Liabilities: WINDLAS's short term assets (₹3.9B) exceed its long term liabilities (₹51.4M).
Debt to Equity History and Analysis
Debt Level: WINDLAS has more cash than its total debt.
Reducing Debt: WINDLAS's debt to equity ratio has reduced from 20.4% to 1.5% over the past 5 years.
Debt Coverage: WINDLAS's debt is well covered by operating cash flow (1487.2%).
Interest Coverage: WINDLAS earns more interest than it pays, so coverage of interest payments is not a concern.